Aurobindo Pharma Ltd vs J B Chemicals Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 14, 2026

Key Highlights

The Latest Trading Price of Aurobindo Pharma Ltd is ₹ 1472 as of 12 Jun 15:30 . The P/E Ratio of Aurobindo Pharma Ltd changed from 9.7 on March 2021 to 0 on March 2026 . This represents a CAGR of -100.00% over 6 yearsThe P/E Ratio of J B Chemicals & Pharmaceuticals Ltd changed from 21.6 on March 2021 to 46.7 on March 2026 . This represents a CAGR of 13.71% over 6 years The Market Cap of Aurobindo Pharma Ltd changed from ₹ 51653 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 6 yearsThe Market Cap of J B Chemicals & Pharmaceuticals Ltd changed from ₹ 9688 crore on March 2021 to ₹ 33126 crore on March 2026 . This represents a CAGR of 22.74% over 6 years The revenue of Aurobindo Pharma Ltd for the Mar '26 is ₹ 8970 crore as compare to the Dec '25 revenue of ₹ 8833 crore. This represent the growth of 1.54% The revenue of J B Chemicals & Pharmaceuticals Ltd for the Mar '26 is ₹ 916.21 crore as compare to the Dec '25 revenue of ₹ 1083 crore. This represent the decline of -15.4% The ebitda of Aurobindo Pharma Ltd for the Mar '26 is ₹ 1867 crore as compare to the Dec '25 ebitda of ₹ 1896 crore. This represent the decline of -1.51% The ebitda of J B Chemicals & Pharmaceuticals Ltd for the Mar '26 is ₹ 185.93 crore as compare to the Dec '25 ebitda of ₹ 314.1 crore. This represent the decline of -40.81% The net profit of Aurobindo Pharma Ltd changed from ₹ 918.22 crore to ₹ 920.84 crore over 8 quarters. This represents a CAGR of 0.14% The net profit of J B Chemicals & Pharmaceuticals Ltd changed from ₹ 176.83 crore to ₹ 101.37 crore over 8 quarters. This represents a CAGR of -24.29% The Dividend Payout of Aurobindo Pharma Ltd changed from 7.53 % on March 2021 to 0 % on March 2026 . This represents a CAGR of -100.00% over 6 yearsThe Dividend Payout of J B Chemicals & Pharmaceuticals Ltd changed from 28.53 % on March 2021 to 52.41 % on March 2026 . This represents a CAGR of 10.67% over 6 years .

About Aurobindo Pharma Ltd

Aurobindo Pharma Limited (APL), one of the world's top 5 manufacturers of semi synthetic penicillins was incorporated in December 1986 as a private limited company.
Mr. P.V.Ramaprasad Reddy, Mr. K.Nityananda Reddy and a small, highly committed group of professionals founded it.
APL is developing, manufacturing and marketing active pharmaceutical ingredients (APIs also referred as bulk actives), intermediates and generic formulations.
The company's robust product portfolio is spread over 6 major product areas encompassing (Antibiotics, Anti-Retro Virals, CVS, CNS, Gastroenterologicals, and Anti-Allergics) with around 65 APIs in the non-antibiotics and over 55 APIs in the antibiotic segment and the World Health Organization (WHO), Geneva, has also approved Aurobindo's products.
APL is running with 29 manufacturing plants across the world conforming to GMP/ISO regulations and an extremely well equipped 9 R&D facilities.

About J B Chemicals & Pharmaceuticals Ltd

J B Chemicals & Pharmaceuticals Limited (JBC) was originally promoted and incorporated in Maharashtra by J B Mody as J B Mody Chemicals & Pharmaceuticals on December 18, 1976.
The Company engage in manufacturing and marketing of diverse range of pharmaceuticals formulations, herbal remedies and Active Pharmaceutical Ingredients (APIs).
It operate manufacturing units at Thane, Belapur, Ankleshwar, Panoli and Daman.
As on March 31, 2026, Torrent Pharma holds an aggregate of 78,357,892 equity shares, representing 48.80% of the equity share capital of the Company as a Promoter. The Bulk Drug Plant at Panoli and Formulation Plant at Daman became operational in Apr.'95.
Products like metrogyl, rantac (a ranitidine-based formulation), and nicardia (a cardiac care medicine) formed a significant part of the company's sales.

FAQs for the comparison of Aurobindo Pharma Ltd and J B Chemicals & Pharmaceuticals Ltd

Which company has a larger market capitalization, Aurobindo Pharma Ltd or J B Chemicals & Pharmaceuticals Ltd?

Market cap of Aurobindo Pharma Ltd is 85,508 Cr while Market cap of J B Chemicals & Pharmaceuticals Ltd is 36,308 Cr

What are the key factors driving the stock performance of Aurobindo Pharma Ltd and J B Chemicals & Pharmaceuticals Ltd?

The stock performance of Aurobindo Pharma Ltd and J B Chemicals & Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Aurobindo Pharma Ltd and J B Chemicals & Pharmaceuticals Ltd?

As of June 14, 2026, the Aurobindo Pharma Ltd stock price is INR ₹1472.25. On the other hand, J B Chemicals & Pharmaceuticals Ltd stock price is INR ₹2261.4.

How do dividend payouts of Aurobindo Pharma Ltd and J B Chemicals & Pharmaceuticals Ltd compare?

To compare the dividend payouts of Aurobindo Pharma Ltd and J B Chemicals & Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.